z-logo
open-access-imgOpen Access
Integration of Computed Tomographic Angiography Spot Sign and Noncontrast Computed Tomographic Hypodensities to Predict Hematoma Expansion
Author(s) -
Andrea Morotti,
Grégoire Boulouis,
Andreas Charidimou,
Kristin Schwab,
Christina Kourkoulis,
Christopher D. Anderson,
M. Edip Gurol,
Anand Viswanathan,
Javier M. Romero,
Steven M. Greenberg,
Jonathan Rosand,
Joshua N. Goldstein
Publication year - 2018
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.118.022010
Subject(s) - medicine , odds ratio , computed tomographic angiography , hematoma , intracerebral hemorrhage , radiology , logistic regression , nuclear medicine , confounding , angiography , subarachnoid hemorrhage
Background and Purpose— Noncontrast computed tomographic (CT) hypodensities represent an alternative to the CT angiography spot sign (SS) to predict intracerebral hemorrhage (ICH) expansion. However, previous studies suggested that these markers predicted hematoma expansion independently from each other. We investigated whether the integration of SS and hypodensity (HD) improved the stratification of ICH expansion risk. Methods— A single-center cohort of consecutive patients with ICH was retrospectively analyzed. Patients with available CT angiography, baseline, and follow-up noncontrast CT images available were included. Trained readers reviewed all the images for SS and HD presence, and the study population was classified into 4 groups: SS and HD negative (SS−HD−), SS positive only (SS+HD−), HD positive only (SS−HD+), and SS and HD positive (SS+HD+). ICH expansion was defined as hematoma growth >33% or >6 mL. The association between SS and HD presence and ICH expansion was investigated with multivariable logistic regression. Results— A total of 745 subjects qualified for the analysis (median age, 73 years; 54.1% men). The rates of ICH expansion were 9.3% in SS−HD−, 25.8% in SS+HD−, 27.4% in SS−HD+, and 55.6% in SS+HD+ patients (P <0.001). After adjustment for potential confounders and keeping SS−HD− subjects as reference, the risk of ICH expansion was increased in SS+HD− and SS−HD+ patients (odds ratio, 2.93,P =0.002 and odds ratio, 3.02,P <0.001, respectively). SS+HD+ subjects had the highest risk of hematoma growth (odds ratio, 9.50;P <0.001).Conclusions— Integration of SS and HD improves the stratification of hematoma growth risk and may help the selection of patients with ICH for antiexpansion treatment in clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom